OTCM
NMXS
Market cap26kUSD
May 13, Last price
0.00USD
Name
Net Medical Xpress Solutions Inc
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Net Medical Xpress Solutions, Inc. specializes in delivering remote medical care solutions to a diverse range of healthcare institutions, including general and specialty hospitals, as well as nursing homes. The company offers services across various medical disciplines, such as remote neurology, neurosurgery, cardiology, orthopedics, wound care, and nephrology. Its technology portfolio includes the proprietary Telemed platform, designed to create tailored telemedicine management systems for its clientele. This platform is complemented by digital paper solutions, a powerful development engine, 'single pane of glass' software for consolidated views, and FDA-approved image viewing tools. Furthermore, it ensures seamless integration with over 43 hospital-based Electronic Medical Record (EMR) systems and supplies essential telemedicine video conferencing hardware along with USB clinical instruments. Beyond technology, Net Medical Xpress also supplies medical professionals and comprehensive administrative support, encompassing credentialing, program oversight, and call center operations. Additionally, it delivers integration services covering electronic prescription and prior authorization software, laboratory and malpractice insurance, extensive provider scheduling, medical translation, and patient rounding services. The company further extends its offerings to include staffing and recruitment, various diagnostic and clinical services, and Amazon cloud solutions. Initially established as New Mexico Software, Inc. in 1995, the organization adopted its current name, Net Medical Xpress Solutions, Inc., in January 2013. Its headquarters are located in Albuquerque, New Mexico.
IPO date
Nov 22, 2000
Employees
23
Domiciled in
US
Incorporated in
US
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||
Revenues | ||||||||
Cost of revenue | ||||||||
Unusual Expense (Income) | ||||||||
NOPBT | ||||||||
NOPBT Margin | ||||||||
Operating Taxes | ||||||||
Tax Rate | ||||||||
NOPAT | ||||||||
Net income | ||||||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | ||||||||
BB yield | ||||||||
| Debt | ||||||||
Debt current | ||||||||
Long-term debt | ||||||||
Deferred revenue | ||||||||
Other long-term liabilities | ||||||||
Net debt | ||||||||
| Cash flow | ||||||||
Cash from operating activities | ||||||||
CAPEX | ||||||||
Cash from investing activities | ||||||||
Cash from financing activities | ||||||||
FCF | ||||||||
| Balance | ||||||||
Cash | ||||||||
Long term investments | ||||||||
Excess cash | ||||||||
Stockholders' equity | ||||||||
Invested Capital | ||||||||
ROIC | ||||||||
ROCE | ||||||||
| EV | ||||||||
Common stock shares outstanding | ||||||||
Price | ||||||||
Market cap | ||||||||
EV | ||||||||
EBITDA | ||||||||
EV/EBITDA | ||||||||
Interest | ||||||||
Interest/NOPBT | ||||||||